Type
. Reversal of T cell unresponsiveness in lepromatous leprosy. Leprosy review [Internet]. 1986;57 Suppl 2:207-12. Available from: http://leprev.ilsl.br/pdfs/1986/v57s2/pdf/v57s2a26.pdf
Type
. Dermatology diagnosis. Tuberculoid leprosy. Boletin de la Asociacion Medica de Puerto Rico. 1986;78(12):514-5.
Type
. Accessory cell function of cells isolated from Mycobacterium leprae-induced granulomas. Cellular immunology. 1986;102(2):346-54.
Type
. In situ characterization of T lymphocyte subpopulations in leprosy in the mangabey monkey. Clinical and experimental immunology [Internet]. 1986;65(2):260-4. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1542319/pdf/clinexpimmunol00119-0048.pdf
Type
. A possible role for E-receptor in immunosuppression in leprosy. Indian journal of leprosy. 1986;58(3):389-94.
Type
Office at the seclusion of a leper. Translated by Rotha Mary Clay, 1909. The American Journal of dermatopathology. 1986;8(3):263-4.
Type
. A multifactorial culture medium with growth factors from leprosy-derived mycobacteria proposed in cultivation trials for Mycobacterium leprae. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1986;54(2):310-1.
Type
. Leprosy and social class in the Middle Ages. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1986;54(2):300-5.
Type
. Prophylactic/therapeutic effects and induction of reversal reactions with thymus transplantation in Mycobacterium leprae-infected nude mice. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1986;54(2):284-8.
Type
. Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1986;54(2):273-83.